SETTING: Gweru Provincial Hospital, Zimbabwe. OBJECTIVES: To evaluate the accuracy of the diagnosis of pulmonary tuberculosis (PTB) in routine circumstances. DESIGN: Prospective cohort study of routinely diagnosed PTB patients between September 2000 and September 2001. RESULTS: Of 300 patients started on treatment, 161 (53.7%) were positive on direct microscopy. Of the 139 sputum-negative patients, 51 (36.7%) were positive after concentration of specimens, an additional 30 (21.6%) were positive on culture only and 58 (19.3% of the total) were negative for all laboratory investigations. There was no difference in sex, human immunodeficiency virus (HIV) serostatus or treatment outcome between the culture-positive and culture-negative presumed PTB patients. Sputum-negative patients had an increased risk of dying during treatment (RR 2.39, P = 0.015). CONCLUSIONS: The laboratory findings reveal that PTB could be confirmed in more than 80% of patients put on treatment in this setting. The treatment outcomes of the remainder did not differ from those in patients with microbiologically confirmed PTB. In a high HIV-prevalent area, clinicians rightly consider the results of the sputum microscopy test as only one element in the decision making process to put a patient on TB treatment.
SETTING: Gweru Provincial Hospital, Zimbabwe. OBJECTIVES: To evaluate the accuracy of the diagnosis of pulmonary tuberculosis (PTB) in routine circumstances. DESIGN: Prospective cohort study of routinely diagnosed PTB patients between September 2000 and September 2001. RESULTS: Of 300 patients started on treatment, 161 (53.7%) were positive on direct microscopy. Of the 139 sputum-negative patients, 51 (36.7%) were positive after concentration of specimens, an additional 30 (21.6%) were positive on culture only and 58 (19.3% of the total) were negative for all laboratory investigations. There was no difference in sex, human immunodeficiency virus (HIV) serostatus or treatment outcome between the culture-positive and culture-negative presumed PTB patients. Sputum-negative patients had an increased risk of dying during treatment (RR 2.39, P = 0.015). CONCLUSIONS: The laboratory findings reveal that PTB could be confirmed in more than 80% of patients put on treatment in this setting. The treatment outcomes of the remainder did not differ from those in patients with microbiologically confirmed PTB. In a high HIV-prevalent area, clinicians rightly consider the results of the sputum microscopy test as only one element in the decision making process to put a patient on TB treatment.
Authors: Robin Wood; Keren Middelkoop; Landon Myer; Alison D Grant; Andrew Whitelaw; Stephen D Lawn; Gilla Kaplan; Robin Huebner; James McIntyre; Linda-Gail Bekker Journal: Am J Respir Crit Care Med Date: 2006-09-14 Impact factor: 21.405
Authors: Thuy T Trinh; Dien T Han; Emily Bloss; Thai H Le; Tung T Vu; Anh H Mai; Nhung V Nguyen; Long T Nguyen; Sy N Dinh; Sara Whitehead Journal: Trans R Soc Trop Med Hyg Date: 2015-10 Impact factor: 2.184
Authors: Munyaradzi Dimairo; Peter MacPherson; Tsitsi Bandason; Abbas Zezai; Shungu S Munyati; Anthony E Butterworth; Stanley Mungofa; Simba Rusikaniko; Katherine Fielding; Peter R Mason; Elizabeth L Corbett Journal: PLoS One Date: 2010-07-28 Impact factor: 3.240
Authors: R Mutetwa; C Boehme; M Dimairo; T Bandason; S S Munyati; D Mangwanya; S Mungofa; A E Butterworth; P R Mason; E L Corbett Journal: Int J Tuberc Lung Dis Date: 2009-10 Impact factor: 2.373
Authors: Trinh Thanh Thuy; N Sarita Shah; Mai Hoang Anh; Do Trong Nghia; Duong Thom; Truong Linh; Dinh Ngoc Sy; Bui Duc Duong; Luu Thi Minh Chau; Phuong Thi Phoung Mai; Charles D Wells; Kayla F Laserson; Jay K Varma Journal: PLoS One Date: 2007-06-06 Impact factor: 3.240
Authors: Muhammad Bakari; Robert D Arbeit; Lillian Mtei; Johnson Lyimo; Richard Waddell; Mecky Matee; Bernard F Cole; Susan Tvaroha; C Robert Horsburgh; Hanna Soini; Kisali Pallangyo; C Fordham von Reyn Journal: BMC Infect Dis Date: 2008-03-06 Impact factor: 3.090
Authors: Lydia Nakiyingi; Bareng A S Nonyane; Willy Ssengooba; Bruce J Kirenga; Damalie Nakanjako; Gloria Lubega; Pauline Byakika-Kibwika; Moses L Joloba; Jerry J Ellner; Susan E Dorman; Harriet Mayanja-Kizza; Yukari C Manabe Journal: PLoS One Date: 2015-07-29 Impact factor: 3.240
Authors: Elizabeth A Reddy; Boniface N Njau; Susan C Morpeth; Kathryn E Lancaster; Alison C Tribble; Venance P Maro; Levina J Msuya; Anne B Morrissey; Gibson S Kibiki; Nathan M Thielman; Coleen K Cunningham; Werner Schimana; John F Shao; Shein-Chung Chow; Jason E Stout; John A Crump; John A Bartlett; Carol D Hamilton Journal: BMC Infect Dis Date: 2014-02-20 Impact factor: 3.090